Skip to main content
Log in

Mutational Screening of Breast Cancer Susceptibility Gene 1 from Early Onset, Bi-lateral, and Familial Breast Cancer Patients in Taiwan

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The BRCA1 gene has been shown to be strongly associated with the occurrence of familial breast cancer. The spectrum of BRCA1 gene mutations in breast cancer patients in various populations has been investigated. In this study, patients in Central Taiwan with breast cancer were screened for BRCA1 mutations by sequencing PCR products spanning the coding region and partial intronic regions of the BRCA1 gene. Twelve polymorphisms in four exons and three introns were found. One mutation was found in one patient with familial breast cancer. Two patients showed LOH at the locus of BRCA1. Also found in the Taiwanese population were two common haplotypes and one rare haplotype of BRCA1. These results suggest that the mutation of BRCA1 contributes little to the occurrence of breast cancer in the Taiwanese population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miki Y, Swensen J, Sattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Brustow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994

    Google Scholar 

  2. Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, Neuhausen S, Skolnick M, Norton L, Goldgar D: Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347: 1643-1645, 1996

    Google Scholar 

  3. van der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E: Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86: 737-740, 2000

    Google Scholar 

  4. van der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E: Founder BRCA1 mutation and two novel germline BRCA2 mutation in breast and/or ovarian cancer families from north-eastern Poland. Hum Mutat 15: 480-481, 2000

    Google Scholar 

  5. Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańnska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J: Founder mutation in the BRCA1 gene in Polish families with breast/ovarian cancer. Am J Hum Genet 66: 1963-1968, 2000

    Google Scholar 

  6. Liede A, Cohen B, Black DM, Davidson RH, Renwick A, Hoodfar E, Olopade OI, Micek M, Anderson V, De Mey R, Fordyce A, Warner E, Dann JL, King MC, Weber B, Narod SA, Steel CM: Evidence of a founder BRCA1 mutation in Scotland. Br J Cancer 82: 705-711, 2000

    Google Scholar 

  7. Andersen TL, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjerg L, Dorum A, Moller P, Weber BL, Borresen-Dale A-L: Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Hum Mutat 11: 166-174, 1998

    Google Scholar 

  8. Markoff A, Sormbrine H, Bogdanova N, Preisler-Adams S, Ganev V, Dworniczak B, Horst J: Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur J Hum Genet 6: 145-150, 1998

    Google Scholar 

  9. Blesa JR, Hernandez-Yago J: Adaptation of conformationsensitive gel electrophoresis to an ALFexpressTM DNA sequencer to screen BRCA1 mutations. BioTechniques 28: 1019-1025, 2000

    Google Scholar 

  10. Hogervorst FBL, Cornelius RS, Bout M, Van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JGM, Vasen HFA, Devilee P, Ommen G-JB: Rapid detection of BRCA1mutations by the protein truncation test. Nat Genet 10: 208-212, 1995

    Google Scholar 

  11. Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G: Detection of BRCA1 mutation by the protein truncation test. Hum Mol Genet 4: 1989-1991, 1995

    Google Scholar 

  12. Ho GH, Phang BH, Ng ISL, Law HY, Soo KC, Ng EH: Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years. Cancer 89: 811-816, 2000

    Google Scholar 

  13. Friedman LS, Ostermeyer A, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8: 399-404, 1994

    Google Scholar 

  14. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc J-F, Belanger C, Dion F, Liu Q, Skolnick M, Goldgar D, Shattuck-Eidens D, Labrie F, Narod SA: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8: 392-398, 1994

    Google Scholar 

  15. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 273: 535-541, 1995

    Google Scholar 

  16. Cough FJ, Weber BL: the Breast Cancer Information Core (BIC), Mutations and polymorphisms in the families early onset breast cancer (BRCA1) gene Hum Mutat 8: 8-18, 1996

    Google Scholar 

  17. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Eng J Med 336: 1409-1415, 1997

    Google Scholar 

  18. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA: Differential contribution of BRCA1 and BRCA2 to early onset breast cancer. N Engl J Med 336: 1416-1421, 1997

    Google Scholar 

  19. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BAJ, Olah E: Analysis of BRCA1 and BRCA2 mutations in hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60: 1242-1246, 1997

    Google Scholar 

  20. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, Lenoir GM: Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60: 486-495, 1997

    Google Scholar 

  21. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA: BRCA1 mutations and breast cancer in the general population. JAMA 279: 922-929, 1998

    Google Scholar 

  22. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR: Prevalence of BRCA1 and BRCA2 gene mutation in patients with early onset breast cancer. J Natl Cancer Inst 91: 943-949, 1999

    Google Scholar 

  23. Inoue R, Fukutomi T, Tshijima T, Matsumoto Y, Sugimura T, Nagao M: Germline mutation of BRCA1 in Japanese breast cancer. Cancer Res 55: 3521-3524, 1995

    Google Scholar 

  24. Matsushima M, Kobayashi K, Emi M, Saito H, Saito J, Suzumori K, Nakamura Y: Mutations analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Hum Mol Genet 4: 1953-1956, 1995

    Google Scholar 

  25. Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Iwase T, Kasumi F, Miki Y, Skolnick MH, Nakamura Y: Mutations in the BRCA1 genes in Japanese breast cancer patients. Hum Mutat 7: 334-339, 1996

    Google Scholar 

  26. Li SS-L, Tseng H-M, Yang T-P, Liu C-H, Teng S-J, Huang H-W, Chen L-M, Kao H-W, Chen J-H, Tseng J-N, Chen A, Hou M-F, Huang T-J, Chang H-T, Mok K-T, Tasi J-H: Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 104: 201-204, 1999

    Google Scholar 

  27. Deng C-X, Brodie SG: Roles of BRCA1 and its interacting proteins. BioEssays 22: 738-737, 2000

    Google Scholar 

  28. Venkitaraman AR: Breast cancer genes and DNA repair. Science 286: 1100-1102, 1999

    Google Scholar 

  29. Scully RCJ, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-436, 1997

    Google Scholar 

  30. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Trry L, Jhanwar S, Berchuk A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Sholnick MH, Kamb A, Wiseman R: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994

    Google Scholar 

  31. Lasko D, Cavenee WK, Nordenskjold M: Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25: 281-314, 1991

    Google Scholar 

  32. Iwase H, Iwata H, Toyama T, Hara Y, Omoto Y, Ando Y, Nakamura T, Kobayashi S: The clinical value of microsatellite instability and a loss in heterozygosity in sporadic breast cancers. Breast Cancer 25: 234-238, 1997

    Google Scholar 

  33. Sztan M, Papai Z, Szendroi M, Looij M, Olah E: Allelic losses from chromosome 17 in human osteosarcomas. Pathol Oncol Res 3: 115-120, 1997

    Google Scholar 

  34. Shen C-Y, Yu J-C, Lo Y-L, Kuo C-H, Yue C-H, Jou Y-S, Huang C-S, Lung J-C, Wu C-W: Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res 60: 3884-3892, 2000

    Google Scholar 

  35. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA: Growth retardation and tumour inhibition by BRCA1. Nat Genet 12: 298-302, 1996

    Google Scholar 

  36. Seery LT, Knowlden JM, Gee JM, Robertson JF, Kenny FS, Ellis IO, Nicholson RI: BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer 84: 258-262, 1999

    Google Scholar 

  37. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinoma. Net Genet 21: 236-240, 1999

    Google Scholar 

  38. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, Okuyama T, Shimada T, Kodama H, Noguchi S, Gazdar AF, Yamaoka Y, Takahashi R: Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res 5: 1249-1261, 1999

    Google Scholar 

  39. Dobrovic A, Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350, 1997

    Google Scholar 

  40. Mancini DM, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK: CpG methylation within the 5_ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16: 1161-1169, 1998

    Google Scholar 

  41. Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18: 1957-1965, 1999

    Google Scholar 

  42. Rice JC, Futscher BW: Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucl Acids Res 28: 3233-3239, 2000

    Google Scholar 

  43. Hakansson S, Johansson O, Johansson U, Sellberg G, Loman N, Gerdes A-M, Holmberg E, Dahl N, Pandis N, Kristoffersson U: Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60: 1068-1078, 1997

    Google Scholar 

  44. Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjakoski K, Pyrhonen S, Kallioniemi O-P: Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum. Mol. Genet. 6: 2309-2315, 1997

    Google Scholar 

  45. Buller RE, Sood AK, Lallas T, Buekers T, Skilling JS: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst 91: 339-346, 1999

    Google Scholar 

  46. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059, 1996

    Google Scholar 

  47. Kainu T, Desper R, Juo S-HH, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi O-P, Trikkonen M, Syrjakosk K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H: Somatic deletion in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci 97: 9603-9608, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, ST., Chen, RA., Kuo, SJ. et al. Mutational Screening of Breast Cancer Susceptibility Gene 1 from Early Onset, Bi-lateral, and Familial Breast Cancer Patients in Taiwan. Breast Cancer Res Treat 77, 133–143 (2003). https://doi.org/10.1023/A:1021386026051

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021386026051

Navigation